The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 3, 2024 | King Thomas Braxton | Director | Grant(A) | 2K | — | $0 |
| Jul 3, 2024 | King Thomas Braxton | Director | Grant(A) | 2K | — | $0 |
| Jul 3, 2024 | Rocamboli Stephen | Director | Grant(A) | 3K | — | $0 |
| Jul 3, 2024 | Rocamboli Stephen | Director | Grant(A) | 3K | — | $0 |
| Jul 3, 2024 | Mikhak Zamaneh | Chief Medical Officer | Grant(A) | 10K | — | $0 |
| Jul 3, 2024 | Mikhak Zamaneh | Chief Medical Officer | Grant(A) | 10K | — | $0 |
| Jul 3, 2024 | Coleman Kirk Allen | Chief Financial Officer | Grant(A) | 10K | — | $0 |
| Jul 3, 2024 | Coleman Kirk Allen | Chief Financial Officer | Grant(A) | 10K | — | $0 |
| Jul 3, 2024 | Roberts Brandi | Director | Grant(A) | 3K | — | $0 |
| Jul 3, 2024 | Roberts Brandi | Director | Grant(A) | 3K | — | $0 |
| Jul 3, 2024 | Mills Robert S | Director | Grant(A) | 3K | — | $0 |
| Jul 3, 2024 | Mills Robert S | Director | Grant(A) | 3K | — | $0 |
| Jul 3, 2024 | Lee Catherine Chai-zon | Director | Grant(A) | 2K | — | $0 |
| Jul 3, 2024 | Lee Catherine Chai-zon | Director | Grant(A) | 2K | — | $0 |
| Jul 3, 2024 | Weisman Harlan F | President and CEO, Director | Grant(A) | 27K | — | $0 |
| Jul 3, 2024 | Weisman Harlan F | President and CEO, Director | Grant(A) | 27K | — | $0 |
| Apr 18, 2024 | Weisman Harlan F | President and CEO, Director | Grant(A) | 45K | — | $0 |
| Apr 18, 2024 | Rocamboli Stephen | Director | Grant(A) | 5K | — | $0 |
| Apr 18, 2024 | Mikhak Zamaneh | Chief Medical Officer | Grant(A) | 5K | — | $0 |
| Apr 18, 2024 | Mikhak Zamaneh | Chief Medical Officer | Grant(A) | 11K | — | $0 |
| Apr 18, 2024 | Coleman Kirk Allen | Chief Financial Officer | Grant(A) | 5K | — | $0 |
| Apr 18, 2024 | Coleman Kirk Allen | Chief Financial Officer | Grant(A) | 11K | — | $0 |
| Apr 18, 2024 | Roberts Brandi | Director | Grant(A) | 5K | — | $0 |
| Apr 18, 2024 | Mills Robert S | Director | Grant(A) | 5K | — | $0 |
| Apr 18, 2024 | Lee Catherine Chai-zon | Director | Grant(A) | 4K | — | $0 |
| Apr 18, 2024 | Patane Michael A | Director | Grant(A) | 4K | — | $0 |
| Apr 18, 2024 | King Thomas Braxton | Director | Grant(A) | 3K | — | $0 |
| Dec 13, 2023 | King Thomas Braxton | Director | Grant(A) | 132K | — | $0 |
| Dec 1, 2023 | Lee Catherine Chai-zon | Director | Grant(A) | 132K | — | $0 |
| Dec 1, 2023 | Patane Michael A | Director | Grant(A) | 132K | — | $0 |
| Dec 1, 2023 | Rocamboli Stephen | Director | Grant(A) | 53K | — | $0 |
| Dec 1, 2023 | Mills Robert S | Director | Grant(A) | 53K | — | $0 |
| Dec 1, 2023 | Roberts Brandi | Director | Grant(A) | 53K | — | $0 |
| Aug 16, 2023 | Carlson Clint Duane | 10% Owner | Sell(S) | 1K | $0.39 | $390 |
| Aug 15, 2023 | Carlson Clint Duane | 10% Owner | Sell(S) | 215K | $0.44 | $95K |
| Aug 15, 2023 | Mikhak Zamaneh | Chief Medical Officer | Buy(P) | 120K | $0.25 | $30K |
| Aug 15, 2023 | Coleman Kirk Allen | Chief Financial Officer | Buy(P) | 20K | $0.25 | $5K |
| Aug 15, 2023 | Mills Robert S | Director | Buy(P) | 40K | $0.25 | $10K |
| Aug 15, 2023 | Roberts Brandi | Director | Buy(P) | 20K | $0.25 | $5K |
| Aug 15, 2023 | Rocamboli Stephen | Director | Buy(P) | 20K | $0.25 | $5K |
| Aug 15, 2023 | Weisman Harlan F | President and CEO, Director | Buy(P) | 600K | $0.25 | $150K |
| Mar 22, 2023 | Coleman Kirk Allen | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Mar 10, 2023 | Mikhak Zamaneh | Chief Medical Officer | Buy(P) | 15K | $0.82 | $12K |
| Mar 10, 2023 | Weisman Harlan F | President and CEO, Director | Buy(P) | 150K | $0.88 | $132K |
| Mar 10, 2023 | Coleman Kirk Allen | Chief Financial Officer | Buy(P) | 12K | $0.79 | $9K |
| Mar 10, 2023 | Rocamboli Stephen | Director | Buy(P) | 13K | $0.80 | $10K |
| Dec 29, 2022 | Rocamboli Stephen | Director | Grant(A) | 33K | — | $0 |
| Dec 29, 2022 | Roberts Brandi | Director | Grant(A) | 21K | — | $0 |
| Dec 29, 2022 | Mills Robert S | Director | Grant(A) | 33K | — | $0 |
| Dec 29, 2022 | Fletcher Aaron G.L. | Director | Grant(A) | 33K | — | $0 |
| Dec 15, 2022 | Weisman Harlan F | President and CEO, Director | Buy(P) | 50K | $1.06 | $53K |
| Dec 3, 2022 | Weisman Harlan F | President and CEO, Director | Grant(A) | 1.8M | — | $0 |
| Nov 22, 2022 | Fletcher Aaron G.L. | Director | Buy(P) | 22K | — | $0 |
| Nov 22, 2022 | Fletcher Aaron G.L. | Director | Buy(P) | 43K | $1.15 | $50K |
| Sep 29, 2022 | Thurman Randy H | Director | Option exercise(M) | 40K | — | $0 |
| Sep 29, 2022 | Thurman Randy H | Director | Sell(S) | 40K | $4.29 | $173K |
| Sep 29, 2022 | Thurman Randy H | Director | Option exercise(M) | 40K | $2.50 | $101K |
| May 20, 2022 | Weisman Harlan F | Director | Buy(P) | 5K | $5.50 | $25K |
| May 18, 2022 | Weisman Harlan F | Director | Buy(P) | 3K | $5.12 | $13K |
| May 17, 2022 | Fletcher Aaron G.L. | Director | Buy(P) | 25K | $5.08 | $125K |
| May 17, 2022 | Coleman Kirk Allen | Chief Financial Officer | Buy(P) | 425 | $4.83 | $2K |
| May 16, 2022 | Fletcher Aaron G.L. | Director | Buy(P) | 85K | $4.86 | $413K |
| May 16, 2022 | Weisman Harlan F | Director | Buy(P) | 3K | $4.74 | $12K |
| May 16, 2022 | Coleman Kirk Allen | Chief Financial Officer | Buy(P) | 1K | $4.40 | $6K |
| May 16, 2022 | Mattes Glenn R. | President and CEO, Director | Buy(P) | 16K | $4.78 | $76K |
| May 16, 2022 | Rocamboli Stephen | Director | Buy(P) | 3K | $4.54 | $14K |
| Apr 4, 2022 | Fletcher Aaron G.L. | Director | Buy(P) | 500K | $6.43 | $3.2M |
| Apr 4, 2022 | Fletcher Aaron G.L. | Director | Buy(P) | 42K | $6.89 | $289K |
| Sep 22, 2021 | Cano Christopher | Chief Operating Officer | Grant(A) | 43K | — | $0 |
| Sep 16, 2021 | Mattes Glenn R. | President and CEO, Director | Buy(P) | 10K | $7.10 | $71K |
| Sep 16, 2021 | Coleman Kirk Allen | CFO, Secretary and Treasurer | Buy(P) | 1K | $7.30 | $7K |
| May 19, 2021 | Fairbairn Malcolm | Director | Buy(P) | 10K | $8.95 | $90K |
| May 18, 2021 | Thurman Randy H | Director | Buy(P) | 1K | $9.40 | $10K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).